LAMPIT is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Bayer Healthcare Pharmaceuticals Inc.. The primary component is Nifurtimox.
Product ID | 50419-750_06512bbe-ca2d-436b-92d0-447aff049c3b |
NDC | 50419-750 |
Product Type | Human Prescription Drug |
Proprietary Name | LAMPIT |
Generic Name | Nifurtimox |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2020-10-01 |
Marketing Category | NDA / NDA |
Application Number | NDA213464 |
Labeler Name | Bayer Healthcare Pharmaceuticals INC. |
Substance Name | NIFURTIMOX |
Active Ingredient Strength | 30 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2020-10-01 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
50419-750 | LAMPIT | nifurtimox |
50419-751 | LAMPIT | nifurtimox |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
LAMPIT 86226905 4702596 Live/Registered |
Bayer Intellectual Property GmbH 2014-03-20 |